Dr. Lois Choi-Kain discusses the prevalence, naturalistic course, and treatments for borderline personality disorder (BPD) and introduces the "Good Psychiatric Management" (GPM) model. The topics covered include challenges faced by BPD patients, the need for sustainable treatment approaches, the significance of listening and understanding patients, and the use of an interpersonal hypersensitivity model in treatment.
01:09:34
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
BPD Prevalence
Borderline Personality Disorder (BPD) is as common as other major mental illnesses, affecting 1-3% of the general population.
It's more prevalent in treatment settings, with 20-25% of inpatients meeting the criteria.
question_answer ANECDOTE
Frequent Flyers
Patients with BPD are often labeled "frequent flyers" due to repeated hospital visits.
This reflects their desire for help and the difficulty in finding effective BPD treatment.
volunteer_activism ADVICE
Destigmatizing BPD
Use the medical model to destigmatize personality disorders, providing understanding and treatment options.
Empower clinicians to avoid harmful reactions and equip them with tools to help BPD patients effectively.
Get the Snipd Podcast app to discover more snips from this episode
Dr. Lois Choi-Kain, Director of the Gunderson Personality Disorders Institute at McLean Hospital and Associate Professor of Psychiatry at Harvard Medical School, introduces us to borderline personality disorder (BPD).
We discuss the prevalence, naturalistic course, and treatments for BPD. We explore BPD using the “Good Psychiatric Management” (GPM) model, which is intended to empower clinicians of all disciplines to manage patients with BPD effectively. We discuss the principles of GPM and walk through some examples of how it might be used in the clinical setting.
(11:30) Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533-545.
(15:00) Gregory R, Sperry SD, Williamson D, Kuch-Cecconi R, Spink GL Jr. High Prevalence of Borderline Personality Disorder Among Psychiatric Inpatients Admitted for Suicidality. J Pers Disord. 2021;35(5):776-787.
(20:45) Kernberg O. Borderline personality organization. J Am Psychoanal Assoc. 1967;15(3):641-685.
(29:30) Choi-Kain LW, Finch EF, Masland SR, Jenkins JA, Unruh BT. What Works in the Treatment of Borderline Personality Disorder. Curr Behav Neurosci Rep. 2017;4(1):21-30.
(33:00) Skodol AE, Gunderson JG, Shea MT, et al. The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. J Pers Disord. 2005;19(5):487-504.
(33:00) Temes CM, Zanarini MC. The Longitudinal Course of Borderline Personality Disorder. Psychiatr Clin North Am. 2018;41(4):685-694.
Psychiatry Boot Camp